UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| 1 |
UBS Group
UBS
|
+$1.56B |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$720M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$652M |
| 4 |
Truist Financial
TFC
|
+$553M |
| 5 |
VanEck Gold Miners ETF
GDX
|
+$298M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.36B |
| 2 |
Alibaba
BABA
|
+$872M |
| 3 |
AABA
Altaba Inc. Common Stock
AABA
|
+$759M |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$503M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$467M |
Sector Composition
| 1 | Technology | 12.45% |
| 2 | Financials | 9.35% |
| 3 | Healthcare | 8.43% |
| 4 | Consumer Discretionary | 6.92% |
| 5 | Industrials | 6.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4576
Moderna
MRNA
$9.9B
| $208K | ﹤0.01% |
10,609
-49,245
| -82% | -$965K |
|
4577
Ocular Therapeutix
OCUL
$2.21B
| $208K | ﹤0.01% |
52,695
+26,812
| +104% | +$106K |
|
|
ESTE
4578
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $208K | ﹤0.01% |
32,847
+11,641
| +55% | +$73.7K |
|
4579
American Superconductor
AMSC
$2.91B
| $207K | ﹤0.01% |
26,474
+10,660
| +67% | +$83.4K |
|
4580
Bassett Furniture
BSET
$141M
| $207K | ﹤0.01% |
12,405
+5,072
| +69% | +$84.6K |
|
4581
CASI Pharmaceuticals
CASI
$27.6M
| $207K | ﹤0.01% |
6,710
+2,554
| +61% | +$78.8K |
|
|
MSD
4582
Morgan Stanley Emerging Markets Debt Fund
MSD
$154M
| $207K | ﹤0.01% |
21,423
-4,569
| -18% | -$44.1K |
|
4583
Noodles & Co
NDLS
$31.1M
| $207K | ﹤0.01% |
37,444
+11,801
| +46% | +$65.2K |
|
4584
Ohio Valley Banc Corp
OVBC
$183M
| $207K | ﹤0.01% |
5,228
+1,949
| +59% | +$77.2K |
|
4585
iShares ESG Aware USD Corporate Bond ETF
SUSC
$1.22B
| $207K | ﹤0.01% |
7,820
+1,357
| +21% | +$35.9K |
|
|
ESSA
4586
DELISTED
ESSA Bancorp
ESSA
| $206K | ﹤0.01% |
12,159
+4,032
| +50% | +$68.3K |
|
4587
Renaissance IPO ETF
IPO
$194M
| $206K | ﹤0.01% |
6,628
+3,720
| +128% | +$116K |
|
4588
Target Hospitality
TH
$857M
| $206K | ﹤0.01% |
41,148
+18,952
| +85% | +$94.9K |
|
|
TCRR
4589
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $206K | ﹤0.01% |
14,453
+5,481
| +61% | +$78.1K |
|
|
CHMA
4590
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $206K | ﹤0.01% |
41,578
+12,940
| +45% | +$64.1K |
|
4591
Stagwell
STGW
$1.37B
| $205K | ﹤0.01% |
73,692
+18,179
| +33% | +$50.6K |
|
4592
Donegal Group Class A
DGICA
$712M
| $204K | ﹤0.01% |
13,791
+4,473
| +48% | +$66.2K |
|
|
FT
4593
Franklin Universal Trust
FT
$197M
| $204K | ﹤0.01% |
26,246
| – | – |
|
4594
MainStreet Bancshares
MNSB
$163M
| $202K | ﹤0.01% |
8,773
+3,077
| +54% | +$70.8K |
|
|
FNCB
4595
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
| $202K | ﹤0.01% |
23,938
+9,720
| +68% | +$82K |
|
4596
BioLife Solutions
BLFS
$1.26B
| $201K | ﹤0.01% |
12,433
+6,226
| +100% | +$101K |
|
4597
ARK Israel Innovative Technology ETF
IZRL
$123M
| $201K | ﹤0.01% |
9,072
+608
| +7% | +$13.5K |
|
4598
Lexicon Pharmaceuticals
LXRX
$443M
| $201K | ﹤0.01% |
48,448
+24,370
| +101% | +$101K |
|
4599
Fidelity MSCI Consumer Staples Index ETF
FSTA
$1.33B
| $200K | ﹤0.01% |
5,304
+1,663
| +46% | +$62.7K |
|
4600
ProShares UltraShort Russell2000
TWM
$31.8M
| $200K | ﹤0.01% |
+796
| New | +$200K |
|